Literature DB >> 7878021

Delineation of the minimal hepatitis B surface antigen-specific B- and T-cell epitope contained within an anti-idiotype-derived pentadecapeptide.

M Rajadhyaksha1, Y Thanavala.   

Abstract

A pentadecapeptide (2F10 peptide) is capable of mimicking the group-specific "a" determinant of human hepatitis B surface antigen (HBsAg) at both the B- and the T-cell level. This peptide represents a sequence on the heavy-chain hypervariable region of a monoclonal "internal image" anti-idiotype (anti-id 2F10) that has partial sequence homology to the "a" determinant epitope of HBsAg. To identify the exact location of the B- and T-cell epitopes, four truncated peptides (peptides 1-4) were synthesized. Using these truncated peptides we have identified the minimal sequence (octapeptide 3) that represents a functional B- and T-cell epitope capable of generating HBsAg-specific antibodies and T cells. This to our knowledge represents the first example of a short peptide sequence functioning as both a B- and a T-cell epitope. We have also identified another T-cell epitope (2F10 peptide 4), but this peptide fails to elicit HBsAg-specific B cells and T cells. Thus, the 2F10 pentadecapeptide is composed of two nonoverlapping, functional T-cell epitopes only one of which is HBsAg specific. Since peptide 3 represents the complementarity-determining region and peptide 4 represents the framework region of the anti-id 2F10, we conclude that an 8-aa sequence from the complementarity-determining region of anti-id 2F10 is sufficient for the molecular mimicry of HBsAg. Finally, our experiments suggest that sequences flanking the minimal immunodominant epitope exert a considerable influence on the nature of antigenic processing that occurs and the resultant T-cell reactivity elicited.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7878021      PMCID: PMC42562          DOI: 10.1073/pnas.92.5.1575

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  A synthetic vaccine constructed by copolymerization of B and T cell determinants.

Authors:  C Leclerc; G Przewlocki; M P Schutze; L Chedid
Journal:  Eur J Immunol       Date:  1987-02       Impact factor: 5.532

2.  Monoclonal 'internal image' anti-idiotypic antibodies of hepatitis B surface antigen.

Authors:  Y M Thanavala; A Bond; R Tedder; F C Hay; I M Roitt
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

3.  Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes.

Authors:  S Briggs; M R Price; S J Tendler
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

4.  The molecular basis of the requirement for antigen processing of pigeon cytochrome c prior to T cell activation.

Authors:  Z Kovac; R H Schwartz
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

5.  Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope.

Authors:  D R Milich; J L Hughes; A McLachlan; G B Thornton; A Moriarty
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Orientation of epitopes influences the immunogenicity of synthetic peptide dimers.

Authors:  J H Cox; J Ivanyi; D B Young; J R Lamb; A D Syred; M J Francis
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

7.  A general method applicable to the search for similarities in the amino acid sequence of two proteins.

Authors:  S B Needleman; C D Wunsch
Journal:  J Mol Biol       Date:  1970-03       Impact factor: 5.469

Review 8.  The interaction between protein-derived immunogenic peptides and Ia.

Authors:  S Buus; A Sette; H M Grey
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

9.  Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production.

Authors:  A Nisonoff; E Lamoyi
Journal:  Clin Immunol Immunopathol       Date:  1981-12

10.  Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.

Authors:  P K Bhatnagar; E Papas; H E Blum; D R Milich; D Nitecki; M J Karels; G N Vyas
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.